Trials / Conditions / Exudative Macular Degeneration

Exudative Macular Degeneration

9 registered clinical trials studyying Exudative Macular Degeneration — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting NCT05093374	Medical University of Vienna	Phase 4
Recruiting	MMP-9 Inhibition for Recalcitrant Wet AMD NCT04504123	University of Iowa	Phase 2
Completed	CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl) NCT03803631	Centre Hospitalier Intercommunal Creteil	—
Completed	Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD NCT01835067	King's College Hospital NHS Trust	Phase 2 / Phase 3
Completed	Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Tre NCT02287298	The Retina Center of St. Louis County, PC	—
Completed	Pilot Study of X-82 in Patients With Wet AMD NCT01674569	Tyrogenex	Phase 1 / Phase 2
Completed	Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept NCT01617148	Rishi Singh	Phase 4
Completed	Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD) NCT01535950	Novartis Pharmaceuticals	Phase 2
Completed	Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema an NCT01473251	Vitreo-Retinal Associates, Michigan	N/A